| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Secretary/ CEO Of Subsidiary | President/ Secretary
1 company
Milligan John C.K. IV is a Secretary/ CEO Of Subsidiary at TherapeuticsMD, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2018 | TXMD Therapeuticsmd, Inc. | President/ Secretary | Sale+OE | 250,000 | $5.85 | $1,462,750.00 | -7.8% | |
| Sep 26, 2018 | TXMD Therapeuticsmd, Inc. | President/ Secretary | Sale+OE | 250,000 | $6.78 | $1,694,250.00 | -7.8% | |
| Sep 11, 2018 | TXMD Therapeuticsmd, Inc. | President/ Secretary | Sale+OE | 250,000 | $6.10 | $1,523,875.00 | -7.8% |